Published in Diabet Med on January 01, 1997
Prevalence and management of diabetes in Korean adults: Korea National Health and Nutrition Examination Surveys 1998-2005. Diabetes Care (2009) 3.13
Development and validation of a patient self-assessment score for diabetes risk. Ann Intern Med (2009) 2.85
A survey of diabetes care in general practice in England and Wales. Br J Gen Pract (2000) 2.65
Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program. Am J Clin Nutr (2008) 2.55
The role of physical activity in the management of impaired glucose tolerance: a systematic review. Diabetologia (2007) 2.51
Use of Read codes in diabetes management in a south London primary care group: implications for establishing disease registers. BMJ (2003) 2.18
Type 2 diabetes and tuberculosis in a dynamic bi-national border population. Epidemiol Infect (2006) 2.09
A novel role for epidermal growth factor receptor tyrosine kinase and its downstream endoplasmic reticulum stress in cardiac damage and microvascular dysfunction in type 1 diabetes mellitus. Hypertension (2012) 1.78
Impaired glucose tolerance: qualitative and quantitative study of general practitioners' knowledge and perceptions. BMJ (2002) 1.62
Activation of vascular bone morphogenetic protein signaling in diabetes mellitus. Circ Res (2010) 1.58
Infant mortality, season of birth and the health of older Puerto Rican adults. Soc Sci Med (2010) 1.48
AGE restriction in diabetes mellitus: a paradigm shift. Nat Rev Endocrinol (2011) 1.46
Wolcott-Rallison syndrome. Orphanet J Rare Dis (2010) 1.45
Body size and shape changes and the risk of diabetes in the diabetes prevention program. Diabetes (2007) 1.45
Current and future economic burden of diabetes among working-age adults in Asia: conservative estimates for Singapore from 2010-2050. BMC Public Health (2016) 1.44
Effective diabetes care: a need for realistic targets. BMJ (2002) 1.43
Pattern of presentation in type 1 diabetic patients at the diabetes center of a university hospital. Ann Saudi Med (2011) 1.42
Prevalence of type 2 diabetes in the States of the co-operation council for the Arab States of the Gulf: a systematic review. PLoS One (2012) 1.42
Population differences in associations between C-reactive protein concentration and adiposity: comparison of young adults in the Philippines and the United States. Am J Clin Nutr (2009) 1.37
Dynamic alpha-helix structure of micelle-bound human amylin. J Biol Chem (2009) 1.36
Intramuscular lipid metabolism, insulin action, and obesity. IUBMB Life (2009) 1.33
Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes Care (2010) 1.33
Fear of hypoglycemia in parents of young children with type 1 diabetes mellitus. J Clin Psychol Med Settings (2008) 1.33
Predictors of health-related quality of life in type II diabetic patients in Greece. BMC Public Health (2007) 1.32
Type 2 diabetes: an epidemic requiring global attention and urgent action. Diabetes Care (2012) 1.29
Race and medication adherence in Medicaid enrollees with type-2 diabetes. J Natl Med Assoc (2006) 1.27
Risk and prevention of type II diabetes: offspring's views. Br J Gen Pract (2001) 1.25
Diabetes and ethnic minorities. Postgrad Med J (2005) 1.25
Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies. Vasc Health Risk Manag (2010) 1.24
Prevalence of diabetic retinopathy in the United Arab Emirates: a cross-sectional survey. BMC Ophthalmol (2007) 1.23
Self-management of type 2 diabetes mellitus: a qualitative investigation from the perspective of participants in a nurse-led, shared-care programme in the Netherlands. BMC Public Health (2008) 1.20
Factors contributing to nonadherence to oral hypoglycemic medications among ambulatory type 2 diabetes patients in Southwestern Nigeria. Pharm Pract (Granada) (2009) 1.20
Adiposity and pathogen exposure predict C-reactive protein in Filipino women. J Nutr (2008) 1.19
Entonox as an analgesic agent during panretinal photocoagulation. Br J Ophthalmol (2002) 1.19
An Australian Aboriginal birth cohort: a unique resource for a life course study of an Indigenous population. A study protocol. BMC Int Health Hum Rights (2003) 1.18
Prospective randomized controlled trial to evaluate effectiveness of registered dietitian-led diabetes management on glycemic and diet control in a primary care setting in Taiwan. Diabetes Care (2009) 1.15
ELSID-Diabetes study-evaluation of a large scale implementation of disease management programmes for patients with type 2 diabetes. Rationale, design and conduct--a study protocol [ISRCTN08471887]. BMC Public Health (2005) 1.14
Diversity in diabetes care programmes and views on high quality diabetes care: are we in need of a standardized framework? Int J Integr Care (2008) 1.13
Prevalence of chronic kidney disease in diabetic adult out-patients in Tanzania. BMC Nephrol (2013) 1.11
Prevalence of common disease-associated variants in Asian Indians. BMC Genet (2008) 1.08
Routine data sources challenge international diabetes Federation extrapolations of national diabetes prevalence in Switzerland. Diabetes Care (2011) 1.05
Diabetes: a time for excitement-and concern. Hopeful signs exist that the ravages of diabetes can be tamed. BMJ (1998) 1.04
Quality of type 2 diabetes management in the states of the Co-operation Council for the Arab States of the Gulf: a systematic review. PLoS One (2011) 1.04
Aqueous concentrations of VEGF and soluble VEGF receptor-1 in diabetic retinopathy patients. J Res Med Sci (2012) 1.03
Prevalence, and associated risk factors, of self-reported diabetes mellitus in a sample of adult urban population in Greece: MEDICAL Exit Poll Research in Salamis (MEDICAL EXPRESS 2002). BMC Public Health (2004) 1.02
Discovery and functional characterization of a novel small molecule inhibitor of the intracellular phosphatase, SHIP2. Br J Pharmacol (2009) 1.02
Autophagy as a therapeutic target in diabetic nephropathy. Exp Diabetes Res (2011) 1.02
Acute and chronic animal models for the evaluation of anti-diabetic agents. Cardiovasc Diabetol (2012) 1.02
A prospective observational study of quality of diabetes care in a shared care setting: trends and age differences (ZODIAC-19). BMJ Open (2012) 1.01
Medicinal chemistry of the anti-diabetic effects of momordica charantia: active constituents and modes of actions. Open Med Chem J (2011) 1.01
Nutritional status and dietary intake of urban residents in Gondar, Northwest Ethiopia. BMC Public Health (2012) 0.99
Liver-specific loss of lipolysis-stimulated lipoprotein receptor triggers systemic hyperlipidemia in mice. Diabetes (2009) 0.98
Epidemiological issues in diabetic retinopathy. Middle East Afr J Ophthalmol (2013) 0.97
Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes. Exp Eye Res (2009) 0.97
Effect of SLCO1B1 genetic polymorphism on the pharmacokinetics of nateglinide. Br J Clin Pharmacol (2006) 0.96
Ultrastructure of islet microcirculation, pericytes and the islet exocrine interface in the HIP rat model of diabetes. Exp Biol Med (Maywood) (2008) 0.96
Physicians' perceptions of the type 2 diabetes multi-disciplinary treatment team: a qualitative study. Diabetes Educ (2011) 0.96
Comparison of type 2 diabetes prevalence estimates in Saudi Arabia from a validated Markov model against the International Diabetes Federation and other modelling studies. Diabetes Res Clin Pract (2014) 0.95
Multi-modal proteomic analysis of retinal protein expression alterations in a rat model of diabetic retinopathy. PLoS One (2011) 0.95
Current trends in the monitoring and treatment of diabetic retinopathy in young adults. Mediators Inflamm (2014) 0.95
A role for the endothelial glycocalyx in regulating microvascular permeability in diabetes mellitus. Cell Biochem Biophys (2007) 0.94
Morphological characteristics of coronary atherosclerosis in diabetes mellitus. Can J Cardiol (2006) 0.94
Cyanidin-3-glucoside-rich extract from Chinese bayberry fruit protects pancreatic β cells and ameliorates hyperglycemia in streptozotocin-induced diabetic mice. J Med Food (2011) 0.94
Serine Protease Activation Essential for Endothelial-Mesenchymal Transition in Vascular Calcification. Circ Res (2015) 0.92
Glycoxidative stress and cardiovascular complications in experimentally-induced diabetes: effects of antioxidant treatment. Open Cardiovasc Med J (2010) 0.92
Redefining the role of thiazolidinediones in the management of type 2 diabetes. Vasc Health Risk Manag (2009) 0.91
Antidiabetic Activities of Aqueous Stem Bark Extract of Strychnoshenningsii Gilg in Streptozotocin-nicotinamide Type 2 Diabetic Rats. Iran J Pharm Res (2012) 0.91
Type 2 diabetes and health care costs in Latin America: exploring the need for greater preventive medicine. BMC Med (2014) 0.91
Parental transmission of type 2 diabetes mellitus in a highly endogamous population. World J Diabetes (2013) 0.89
Sociodemographic factors responsible for blindness in diabetic Egyptian patients. Clin Ophthalmol (2011) 0.89
Health beliefs among individuals at increased familial risk for type 2 diabetes: implications for prevention. Diabetes Res Clin Pract (2012) 0.89
Advanced glycation end products (AGE) and diabetes: cause, effect, or both? Curr Diab Rep (2014) 0.89
Hepatoprotective and Pancreatoprotective Properties of the Ethanolic Extract of Nigerian Propolis. J Intercult Ethnopharmacol (2015) 0.88
Ca2+-sparks constitute elementary building blocks for global Ca2+-signals in myocytes of retinal arterioles. Cell Calcium (2006) 0.88
Celiac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features. Mayo Clin Proc (2005) 0.88
Diabetic factors associated with gastrointestinal symptoms in patients with type 2 diabetes. World J Gastroenterol (2010) 0.88
Simultaneous transdermal extraction of glucose and lactate from human subjects by reverse iontophoresis. Int J Nanomedicine (2008) 0.88
Retinopathy in a novel model of metabolic syndrome and type 2 diabetes: new insight on the inflammatory paradigm. FASEB J (2014) 0.87
Managing chronic inflammation in the aging diabetic patient with CKD by diet or sevelamer carbonate: a modern paradigm shift. J Gerontol A Biol Sci Med Sci (2012) 0.87
Positron emission tomography imaging of the glucagon-like peptide-1 receptor in healthy and streptozotocin-induced diabetic pigs. Eur J Nucl Med Mol Imaging (2014) 0.87
Incorporating a generic model of subcutaneous insulin absorption into the AIDA v4 diabetes simulator: 1. a prospective collaborative development plan. J Diabetes Sci Technol (2007) 0.87
Frequency of diabetic retinopathy in the adult population in China: the Beijing Eye Study 2001. Int Ophthalmol (2009) 0.87
Coronary revascularization in diabetic patients: Current state of evidence. Exp Clin Cardiol (2011) 0.87
Prevalence of dysglycemia in Calabar: a cross-sectional observational study among residents of Calabar, Nigeria. BMJ Open Diabetes Res Care (2014) 0.86
Prevalence of undiagnosed abnormal glucose tolerance in adult patients cared for by general practitioners in Hungary. Results of a risk-stratified screening based on FINDRISC questionnaire. Med Sci Monit (2013) 0.86
Vascular stem cells in diabetic complications: evidence for a role in the pathogenesis and the therapeutic promise. Cardiovasc Diabetol (2012) 0.86
Surgical management of diabetic retinopathy. Middle East Afr J Ophthalmol (2013) 0.86
Comparison of skin microvascular reactivity with hemostatic markers of endothelial dysfunction and damage in type 2 diabetes. Vasc Health Risk Manag (2008) 0.86
Benefits gained, benefits lost: comparing baby boomers to other generations in a longitudinal cohort study of self-rated health. Milbank Q (2015) 0.85
Age-related alterations in retinal neurovascular and inflammatory transcripts. Mol Vis (2011) 0.85
Food pattern, lifestyle and diabetes mellitus. Int J High Risk Behav Addict (2014) 0.85
Effect of the PPARG2 Pro12Ala polymorphism and clinical risk factors for diabetes mellitus on HbA1c in the Japanese general population. J Epidemiol (2012) 0.85
Matrix Gla protein species and risk of cardiovascular events in type 2 diabetic patients. Diabetes Care (2013) 0.85
Medicinal Chemistry and Applications of Incretins and DPP-4 Inhibitors in the Treatment of Type 2 Diabetes Mellitus. Open Med Chem J (2011) 0.84
Opportunities for using lipoprotein subclass profile by nuclear magnetic resonance spectroscopy in assessing insulin resistance and diabetes prediction. Metab Syndr Relat Disord (2012) 0.84
Effect of NR-Salacia on post-prandial hyperglycemia: A randomized double blind, placebo-controlled, crossover study in healthy volunteers. Pharmacogn Mag (2013) 0.84
Cardiovascular disease in diabetic nephropathy patients: cell adhesion molecules as potential markers? Vasc Health Risk Manag (2005) 0.84
Characterization of human myotubes from type 2 diabetic and nondiabetic subjects using complementary quantitative mass spectrometric methods. Mol Cell Proteomics (2011) 0.84
Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med (2006) 18.51
Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum (1977) 8.55
Counting birds, bees, and NCDs. Lancet (1992) 6.46
Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med (2002) 6.32
International Diabetes Federation: a consensus on Type 2 diabetes prevention. Diabet Med (2007) 3.88
Age-standardization in epidemiological data. Int J Epidemiol (1994) 3.17
Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med (2011) 2.74
Prevalence of diabetes and impaired glucose tolerance in the biracial (Melanesian and Indian) population of Fiji: a rural-urban comparison. Am J Epidemiol (1983) 2.60
Simple method for measurement of lower extremity muscle strength. Am J Med (1985) 2.59
Antibodies to glutamic acid decarboxylase as predictors of insulin-dependent diabetes mellitus before clinical onset of disease. Lancet (1994) 2.50
Calcium pyrophosphate dihydrate crystal deposition disease--1975. Arthritis Rheum (1976) 2.47
Remitting, seronegative, symmetrical synovitis with pitting edema--13 additional cases. J Rheumatol (1990) 2.44
Geographic variation of inflammatory bowel disease within the United States. Gastroenterology (1991) 2.33
Ethnic comparisons of the cross-sectional relationships between measures of body size with diabetes and hypertension. Obes Rev (2008) 2.32
Diet, nutrition and the prevention of type 2 diabetes. Public Health Nutr (2004) 2.25
Remitting seronegative symmetrical synovitis with pitting edema. RS3PE syndrome. JAMA (1985) 2.22
Crystal-induced inflammation in canine joints. I. An experimental model with quantification of the host response. J Exp Med (1966) 2.21
Recurrent acute inflammation associated with focal apatite crystal deposition. Arthritis Rheum (1966) 2.17
The diabetes epidemic in Australia: prevalence, patterns and the public health. Med J Aust (1995) 2.03
"Milwaukee shoulder"--association of microspheroids containing hydroxyapatite crystals, active collagenase, and neutral protease with rotator cuff defects. I. Clinical aspects. Arthritis Rheum (1981) 1.79
Identification of hydroxyapatite crystals in synovial fluid. Arthritis Rheum (1979) 1.75
Tendon ruptures in patients with systemic lupus erythematosus treated with corticosteroids. Arthritis Rheum (1975) 1.72
Trends in the prevalence and incidence of diabetes: non-insulin-dependent diabetes mellitus. World Health Stat Q (1988) 1.68
Calcium pyrophosphate dihydrate crystal deposition in neuropathic joints. Four cases of polyarticular involvement. Ann Intern Med (1973) 1.59
The global epidemiology of non-insulin-dependent diabetes mellitus and the metabolic syndrome. J Diabetes Complications (1997) 1.58
Crystal-induced inflammation in canine joints. II. Importance of polymorphonuclear leukocytes. J Exp Med (1966) 1.58
The thrifty genotype in non-insulin dependent diabetes. BMJ (1993) 1.57
Bimodality of fasting and two-hour glucose tolerance distributions in a Micronesian population. Diabetes (1978) 1.55
Type 2 (non-insulin-dependent) diabetes--an epidemiological overview. Diabetologia (1982) 1.55
Effect of topical capsaicin in the therapy of painful osteoarthritis of the hands. J Rheumatol (1992) 1.54
Dietary Westernisation: conceptualisation and measurement in Mauritius. Public Health Nutr (2005) 1.51
"Milwaukee shoulder"--association of microspheroids containing hydroxyapatite crystals, active collagenase, and neutral protease with rotator cuff defects. II. Synovial fluid studies. Arthritis Rheum (1981) 1.50
Glucose tolerance in Papua New Guinea: ethnic differences, association with environmental and behavioural factors and the possible emergence of glucose intolerance in a highland community. Med J Aust (1989) 1.46
Outcome and cost analysis of scheduled versus emergency scleral buckling surgery. Ophthalmology (1992) 1.45
Increasing prevalence of Type 2 diabetes mellitus in all ethnic groups in Mauritius. Diabet Med (2005) 1.44
Choice and availability of takeaway and restaurant food is not related to the prevalence of adult obesity in rural communities in Australia. Int J Obes (Lond) (2005) 1.42
The inflammatory reaction to microcrystalline sodium urate. Arthritis Rheum (1965) 1.41
Treatment of intractable rheumatoid arthritis with combined cyclophosphamide, azathioprine, and hydroxychloroquine. A follow-up study. JAMA (1986) 1.41
Release of collagenase, neutral protease, and prostaglandins from cultured mammalian synovial cells by hydroxyapatite and calcium pyrophosphate dihydrate crystals. Arthritis Rheum (1981) 1.40
Limitation of fasting plasma glucose for the diagnosis of diabetes mellitus. Diabetes Care (1982) 1.40
The reflex sympathetic dystrophy syndrome. I. Clinical and histologic studies: evidence for bilaterality, response to corticosteroids and articular involvement. Am J Med (1976) 1.40
Patterns of radiographic abnormalities associated with basic calcium phosphate and calcium pyrophosphate dihydrate crystal deposition in the knee. Ann Rheum Dis (1986) 1.40
Polysynovitis associated with acute Epstein-Barr virus infection. J Rheumatol (1998) 1.39
Controlled study of the use of autologous serum in dry eye patients. Cornea (2001) 1.39
The high prevalence of diabetes mellitus on a Central Pacific Island. Diabetologia (1977) 1.38
High incidence of type 2 diabetes and increasing conversion rates from impaired fasting glucose and impaired glucose tolerance to diabetes in Mauritius. J Intern Med (2004) 1.38
Treatment of rheumatoid joint inflammation with triamcinolone hexacetonide. Arthritis Rheum (1972) 1.38
Diseases associated with calcium pyrophosphate dihydrate crystal deposition. Am J Med (1974) 1.37
Plasma uric acid level and its association with diabetes mellitus and some biologic parameters in a biracial population of Fiji. Am J Epidemiol (1988) 1.36
Clinical profile of lean NIDDM in South India. Diabetes Res Clin Pract (1997) 1.35
The natural history of impaired glucose tolerance in the Micronesian population of Nauru: a six-year follow-up study. Diabetologia (1984) 1.32
Primary prevention of non-insulin-dependent diabetes mellitus. Diabetes Metab Rev (1992) 1.32
Synovial origins of Rice bodies in joint fluid. Arthritis Rheum (1980) 1.31
"Milwaukee shoulder"--association of microspheroids containing hydroxyapatite crystals, active collagenase, ad neutral protease with rotator cuff defects. III. Morphologic and biochemical studies of an excised synovium showing chondromatosis. Arthritis Rheum (1981) 1.31
The prevalence of diabetes in the rural and urban Polynesian population of Western Samoa. Diabetes (1981) 1.30
Disease monitoring. Lancet (1993) 1.30
Elevated inorganic pyrophosphate concentrations in synovial fluids in osteoarthritis and pseudogout. J Lab Clin Med (1974) 1.30
Improving glucose management: ten steps to get more patients with type 2 diabetes to glycaemic goal. Int J Clin Pract (2005) 1.27
Epidemiology of systemic lupus erythematosus in rural Wisconsin. Lupus (2005) 1.27
Release of platelet constituents by monosodium urate crystals. J Clin Invest (1977) 1.26
Why are today's medical students choosing high-technology specialties over internal medicine? N Engl J Med (1987) 1.24
Inorganic pyrophosphate concentrations in the synovial fluid of arthritic patients. J Lab Clin Med (1971) 1.21
Differential membranolytic effects of microcrystalline sodium urate and calcium pyrophosphate dihydrate. J Exp Med (1971) 1.21
Milwaukee Shoulder syndrome: eleven additional cases with involvement of the knee in seven (basic calcium phosphate crystal deposition disease). Semin Arthritis Rheum (1984) 1.21
The reflex sympathetic dystrophy syndrome. A comprehensive analysis using fine-detail radiography, photon absorptiometry, and bone and joint scintigraphy. Radiology (1975) 1.20
Crystal-induced endogenous pyrogen production. A further look at gouty inflammation. Arthritis Rheum (1985) 1.20
Rheumatoid nodulosis: an unusual variant of rheumatoid disease. Arthritis Rheum (1975) 1.19
Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group. Diabetologia (1999) 1.18
New diagnostic criteria for diabetes mellitus. Med J Aust (1982) 1.17
Genetics of diabetes in Nauru: effects of foreign admixture, HLA antigens and the insulin-gene-linked polymorphism. Diabetologia (1983) 1.17
Suppressive effects of indomethacin on crystal-induced inflammation in canine joints and on neutrophilic motility in vitro. J Pharmacol Exp Ther (1967) 1.17
99m-technetium scintiphotography in arthritis. II. Its nonspecificity and clinical and roentgenographic correlations in rheumatoid arthritis. Arthritis Rheum (1970) 1.16
Non-insulin-dependent diabetes (NIDDM) in a newly independent Pacific nation: the Republic of Kiribati. Diabetes Care (1984) 1.14
Factors affecting the solubility of calcium pyrophosphate dihydrate crystals. J Clin Invest (1975) 1.13
The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes. Diabetologia (2005) 1.12
Diabetes mellitus in an urbanized, isolated Polynesian population. The Funafuti survey. Diabetes (1977) 1.12
Mitogenic effects of hydroxyapatite and calcium pyrophosphate dihydrate crystals on cultured mammalian cells. Arthritis Rheum (1984) 1.11
Diagnostic thresholds for diabetes: the association of retinopathy and albuminuria with glycaemia. Diabetes Res Clin Pract (2006) 1.11
Leptin predicts the development of diabetes in Mauritian men, but not women: a population-based study. Int J Obes (Lond) (2007) 1.11
Epidemiology of diabetes and its macrovascular manifestations in Pacific populations: the medical effects of social progress. Diabetes Care (1980) 1.11
Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate. J Rheumatol (1991) 1.10
Osteonecrosis, fractures, and protrusio acetabuli secondary to x-irradiation therapy for prostatic carcinoma. J Rheumatol (1987) 1.07
Protein binding to monosodium urate monohydrate, calcium pyrophosphate dihydrate, and silicon dioxide crystals. I. Physical characteristics. J Lab Clin Med (1977) 1.07
HLA and non-insulin dependent diabetes in Fiji indians. Med J Aust (1981) 1.07
Nutrient intakes in an urbanized Micronesian population with a high diabetes prevalence. Am J Clin Nutr (1979) 1.06
Release of pyrophosphate by normal mammalian articular hyaline and fibrocartilage in organ culture. Arthritis Rheum (1981) 1.06
The prevalence of coronary heart disease in the multi-ethnic and high diabetes prevalence population of Mauritius. J Intern Med (1993) 1.06
CLearance of calcium pyrophosphate dihydrate crystals in vivo. II. Studies using triclinic crystals doubly labeled with 45Ca and 85Sr. Arthritis Rheum (1979) 1.05
A historical note: Leeuwenhoek's description of crystals from a gouty tophus. Arthritis Rheum (1970) 1.05
Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis. Am J Ophthalmol (2001) 1.04
Cataract extraction in a major ophthalmic hospital: day-case or overnight stay? Clin Experiment Ophthalmol (2000) 1.04
Running elevates plasma beta-endorphin immunoreactivity and ACTH in untrained human subjects. Proc Soc Exp Biol Med (1981) 1.04
Intractable rheumatoid arthritis. Treatment with combined cyclophosphamide, azathioprine, and hydroxychloroquine. JAMA (1982) 1.04
Measurement of inorganic pyrophosphate in biological fluids. Elevated levels in some patients with osteoarthritis, pseudogout, acromegaly, and uremia. J Clin Invest (1973) 1.04
Inorganic pyrophosphate pool size and turnover rate in arthritic joints. J Clin Invest (1975) 1.03
Crystal-induced inflammation of the joints. Annu Rev Med (1970) 1.03